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Summary 
 
Background 
Emergency abdominal surgery is associated with poor patient outcomes. We studied the 
effectiveness of a national quality improvement (QI) programme to implement a care 
pathway to improve survival for these patients. 
 
Methods  
Stepped-wedge cluster randomised trial of patients aged ≥40 years undergoing emergency 
open major abdominal surgery. Hospitals were organised into 15 geographical clusters and 
commenced the QI programme in random order, based on a computer generated random 
sequence, over an 85-week period. The trial included an ethnographic study in six hospitals. 
The primary outcome measure was mortality within 90 days of surgery. Analyses were 
performed on an intention-to-treat basis. The primary outcome was analysed using a mixed-
effects parametric survival model, adjusting for time-related effects.  
 
Findings 
Of 15,873 eligible patients from 93 NHS hospitals, primary outcome data were analysed for 
8482 patients in the usual care group and 7374 in the QI group. The primary outcome 
occurred in 1393 patients in the usual care group (16%) compared with 1210 patients in the 
QI group (16%) (HR QI vs usual care: 1.11 [0.96-1.28]). There were only modest overall 
improvements in processes of patient care following QI implementation. The ethnographic 
study revealed good QI engagement but limited time and resources to implement change, 
affecting which processes teams addressed, the rate of change and eventual success.  
 
Interpretation 
There was no survival benefit from a QI programme to implement a care pathway for patients 
undergoing emergency abdominal surgery. The success of the QI intervention may have been 
limited by the time and resources needed to improve patient care.  
 
Funding 
National Institute for Health Research, Health Services and Delivery Research.  
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Research in context  
 
Evidence before this study  
Emergency abdominal surgery is associated with poor post-operative outcomes. Around 
30,000 patients undergo this type of surgery each year in the UK National Health Service 
(NHS), with 30-day mortality rates in excess of 10% and wide variation in standards of care 
between hospitals. We searched for peer reviewed publications describing the effects of 
quality improvement programmes on survival for adult patients using the terms ‘emergency 
abdominal surgery’ and ‘emergency laparotomy’. Several groups have studied the effect of 
quality improvement initiatives to implement individual interventions or ‘care bundles’ of 
several treatments, and so improve care for these patients. Overall, the findings of these small 
studies suggest survival benefit, but most utilised weak study designs associated with a high 
risk of bias. The feasibility and benefit of a national quality improvement programme to 
implement a more extensive acute care pathway for this patient group remain uncertain.  
 
Added value of this study  
We conducted a large national quality improvement programme to implement a care 
pathway for patients undergoing emergency abdominal surgery. In a stepped-wedge cluster 
randomised trial of 15,873 patients aged ≥40 years, in 93 NHS hospitals organised into fifteen 
geographical clusters, we did not identify any survival benefit at either 90 or 180 days after 
surgery. There was good engagement with the quality improvement programme but staff had 
limited time and resources to implement change. Consequently, there were only modest 
overall changes in the processes of patient care from before to after quality improvement 
implementation. There were wide variations in intervention fidelity between hospitals, with 
differences in the processes teams tried to change, the rate of change and eventual success.  
 
Implications of all the available evidence  
Despite the success of some smaller projects, there was no survival benefit from a national 
quality improvement programme to implement a care pathway for patients undergoing 
emergency abdominal surgery. To succeed, large national quality improvement programmes 
need to allow for differences between hospitals and ensure teams have both the time and 
resources needed to improve patient care.   
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Introduction 
More than 1.53 million adults undergo in-patient surgery in the UK National Health Service 
(NHS) each year with a 30-day mortality of 1.5%.1 However, patients undergoing emergency 
abdominal surgery have a much greater risk of death.2,3 Around 30,000 patients undergo 
these procedures in NHS hospitals each year, with 30-day mortality rates in excess of 10%.2 
There are widespread variations in standards of care between hospitals,2,3 including the 
involvement of senior surgeons and anaesthetists and post-operative admission to critical 
care. These variations have been associated with differences in mortality rates.2,3  
 
In small studies, quality improvement initiatives to implement either individual interventions 
or ‘bundles’ including several treatments have been associated with improved survival after 
emergency abdominal surgery.4-7 In a report commissioned by the UK Department of Health, 
the Royal College of Surgeons of England proposed more extensive improvements to quality 
of care for this patient group.8 Recommendations included consultant led decision making, 
cardiac output guided fluid therapy and early admission to critical care. However, the 
feasibility of implementing such an extensive acute care pathway on a national scale, and the 
benefits of doing so, remain uncertain. There are good examples where discrete quality 
improvement interventions have been associated with improved patient outcomes,9,10 but 
others yielded disappointing results.11,12 This is especially true for complex interventions 
requiring co-ordinated change across a healthcare system.13,14 The benefits of quality 
improvement initiatives are self-evident to some,15  but others question the value of these 
projects, citing high costs, failure to engage clinicians and a lack of scientific rigour.16,17 
Despite this, the direction in healthcare policy is towards ever more widespread use of quality 
improvement to drive large scale change.18 
 
The launch of the National Emergency Laparotomy Audit in December 2013,2 provided a 
unique opportunity to study a quality improvement programme to implement a complex care 
pathway at a national level. We conducted a stepped-wedge cluster randomised trial, with an 
embedded ethnographic evaluation, to evaluate the hypothesis that implementing this 
pathway would improve survival following emergency abdominal surgery in NHS hospitals.   
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Methods 
Study design and participants 
EPOCH was a multi-centre, stepped-wedge cluster randomised trial of a quality improvement 
(QI) intervention to promote the implementation of a perioperative care pathway for patients 
undergoing emergency abdominal surgery. The trial protocol was published prospectively by 
the Lancet (Protocol 13PRT/7655) and on the trial website (www.epochtrial.org/protocol). 
The trial was prospectively registered at isrctn.com on 27th February 2014 but a registration 
number was not issued until 7th March 2014 (ISRCTN80682973).  
 
NHS hospitals delivering an emergency general surgical service were eligible for inclusion 
provided they undertook a significant volume of emergency abdominal surgery cases and 
contributed data to the National Emergency Laparotomy Audit (NELA). Hospitals were 
required to nominate specialty leads from surgery, anaesthesia and critical care, and to secure 
support from their NHS Trust Board or equivalent. Hospitals which were already 
implementing a care pathway to improve treatment for this patient group were excluded. 
Patients were eligible for inclusion in the data analysis if they were 40 years or older, and 
undergoing emergency open abdominal surgery in a participating hospital during the 85-week 
trial period from 3rd March 2014 to 19th October 2015. Patients were excluded from the 
analysis if they were undergoing a simple appendicectomy, surgery related to organ 
transplant, gynaecological surgery, laparotomy for traumatic injury, treatment of 
complications of recent elective surgery or if they had previously been included in the EPOCH 
trial. 
 
Data collection 
Trial data were collected through the NELA database (www.nela.org.uk), and then linked 
using unique patient identifiers to Hospital Episode Statistics and Office for National Statistics 
in England and Wales, and the Information Services Division of NHS Scotland, to provide data 
describing mortality and hospital re-admissions. The trial was approved by the East Midlands 
(Nottingham 1) Research Ethics Committee (Ref: 13/EM/0415). Data were analysed without 
individual patient consent in accordance with section 251 of the National Health Services Act 
2006. 
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Randomisation and masking 
We planned to include fifteen geographical clusters of five to seven hospitals. The QI 
intervention lasted 80 weeks with one geographical cluster commencing the intervention 
each five-week step from the 2nd to the 16th time period. Clusters were randomly assigned 
to one of 15 start dates for the QI intervention by an independent statistician using a 
computer-generated random allocation sequence. Because each geographical area started in 
the usual care group, and ended in the QI group, there were 17 time periods in total. Local 
investigators in each geographical area were notified 12 weeks in advance of activation of the 
quality improvement programme at their hospital. Because they were engaged in delivery of 
the intervention, it was not possible to mask hospital staff. Patients were masked to study 
group allocation. The organisation of hospitals into geographical clusters minimised any 
contamination between sites due to natural workforce movements between hospitals. 
 
Trial intervention 
The EPOCH trial care pathway was developed through an evidence based Delphi consensus 
process to update existing guidelines published by the Royal College of Surgeons of England.8 
A list of the 37 component interventions is provided in the supplementary file and 
Supplementary figure 1, and a full summary of evidence grading is available on the trial 
website (www.epochtrial.org). Because of the stepped-wedge trial design, the duration of the 
QI intervention varied between clusters from 5 to 80 weeks. We developed an evidence-
based QI programme to change the practice and culture of care for patients undergoing 
emergency abdominal surgery. QI leads from each stakeholder discipline (surgery, 
anaesthesia, and critical care) were tasked with leading a hospital wide improvement 
programme to implement the care pathway with the support and guidance of the national 
EPOCH QI team. The key features of the quality improvement methodology were 1) Reframing 
the high mortality rates for these patients as a ‘social problem’ requiring re-organisation of 
existing care processes rather than technical innovation; 2) Supporting QI leads to engage 
their frontline staff and executive leaders in the change process; 3) Training local QI leads in 
basic improvement skills based around the Model for Improvement;19 and 4) Supporting 
teams to analyse and feed back key process measure data to their colleagues to drive change. 
The EPOCH QI team provided a one-day activation and education meeting for each 
geographical cluster shortly before or during the first week of activation. The purpose of this 
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meeting was to develop the knowledge, skills and attitudes that the QI leaders required to 
achieve change. Nominated QI Leads were informed 12 weeks before the date of activation 
to the intervention. Five weeks before activation, QI leads were sent a ‘pre-activation’ 
checklist which included planning a local stakeholder meeting, recruiting colleagues to their 
change teams and developing a presentation entitled ‘Where we are now’ including baseline 
data, local challenges and ideas for improvement to share at the cluster activation meeting. 
The EPOCH QI team provided further advice and support by phone and email. All QI resources, 
including data analysis tools, training materials and promotional documents were available 
online through a Virtual Learning Environment. Clusters were offered a half-day follow-up 
meeting 16 weeks after activation so that QI leads and their teams could meet and share 
experiences. There were also two national meetings to facilitate shared learning during the 
trial period. QI leads were only eligible to attend these if their hospital had been activated to 
the trial intervention.  
 
Outcome measures 
The primary outcome measure was all-cause mortality within 90 days following surgery. 
Secondary outcomes were all-cause mortality within 180 days following surgery, duration of 
hospital stay after surgery and hospital re-admission within 180 days of surgery. We selected 
ten predefined process measures (key components of the care pathway) for inclusion in the 
main report: 1) consultant led decision to operate, 2) consultant review of patient before 
surgery, 3) pre-operative documentation of risk, 4) time from decision to operate to entry 
into operating theatre, 5) patient entered operating theatre within time-frame specified by 
their urgency (<2 hours, 2-6 hours, 6-18 hours, or >18 hours), 6) consultant surgeon present 
in operating theatre, 7) consultant anaesthetist present in operating theatre, 8) cardiac 
output guided fluid therapy used during surgery, 9) serum lactate measured at end of surgery 
and 10) critical care admission immediately after surgery. 
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Statistical analysis 
A stepped-wedge design was chosen to improve statistical power by facilitating within-cluster 
comparison. Sample size calculations were based on the Hussey & Hughes approach,20 for an 
analysis with fixed time effects and random cluster effects, modified to exclude data collected 
during the five-week period in which the intervention commenced in individual clusters. Using 
Hospital Episodes Statistics data (www.epochtrial.org/protocol), we estimated that 27,540 
eligible patients would be registered across 90 NHS hospitals over 85 weeks, with a 90-day 
mortality rate of 25% in the usual care group, and a between hospital coefficient of variation 
of 0.15. Assuming a constant case-load (18 patients per 5 weeks per hospital), independent 
hospital effects and a 5% significance level, the trial would have 92% power to detect a 
reduction in 90-day mortality from 25% to 22%. If the assumption of independent hospital 
effects was not met, and the 15 geographical clusters functioned effectively as 15 large 
hospitals, power would be reduced to 83%.  
 
All analyses were conducted according to intention-to-treat principles. All eligible patients 
with available outcome data were included in the analysis, and analysed according to the 
randomisation schedule.21 Patients who presented during the 5-week time period 
immediately after quality improvement activation were excluded from the analysis. Hospitals 
that initially agreed to participate but subsequently withdrew prior to the trial start date were 
excluded, however hospitals which withdrew after the trial start date, or did not implement 
the intervention, were included in the analysis. Hospitals which merged with other hospitals 
during the trial period were included in the analysis up to the point of the merger. 
 
We were unable to procure data describing survival status after hospital discharge for 
patients in Wales. We therefore changed our primary analysis from binary to a time to event 
approach allowing inclusion of mortality events censored at hospital discharge. All analyses 
included time period as a fixed effect using indicator variables, and adjusted for age, gender, 
and indication for surgery using fixed factors.22 Age was included as a continuous covariate, 
assuming a linear association with outcome.23 Missing baseline data for indication for surgery 
were handled using a missing indicator approach.24 All-cause mortality within 90 days of 
surgery was analysed using a mixed-effects parametric survival model with a Weibull survival 
distribution. The model included random-intercepts for geographical area, hospital and 
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hospital-period (i.e. the time-period within hospital). This allowed additional correlation 
between patients in the same hospital and the same period, compared to patients in other 
periods, as is recommended.25 All-cause mortality within 180 days was analysed using the 
same approach. Duration of hospital stay was analysed using competing risk time-to-event 
models, with mortality before the outcome event acting as the competing risk, and robust 
standard errors to account for clustering by geographical area. The hazard ratio from this 
analysis measures the relative probability of hospital discharge between treatment arms, with 
HR<1 indicating a lower probability of discharge in the QI group (and therefore longer hospital 
stay). Hospital readmission within 180 days was analysed using the same approach (with a 
HR<1 indicating a lower probability of re-admission).  
 
Ethnographic study and process evaluation 
As part of the wider EPOCH project, a prospective ethnographic evaluation was undertaken 
in six trial sites by researchers outside the main trial team. Ethnography draws on 
anthropological methods, including observation and interview, to provide a rich description 
of events that occur within a specific context. A maximum variation sample of sites was 
chosen with criteria focussed on size, surgical volume and discipline of the primary QI lead. A 
process evaluation was conducted to describe the delivery of the QI intervention. Data were 
collected describing the activity of QI teams and an exit questionnaire was completed by local 
QI leads to report their experience of the quality improvement process. All data were 
collected and analysed prior to the main trial analysis. Detailed methods are presented in the 
full reports.26,27 In this report, we summarise key themes to provide the perspective needed 
to interpret our main findings. 
 
Role of the funding source 
The funder (National Institute for Health Research, Health Services & Delivery Research 
programme) had no role in study design, data collection, data analysis, data interpretation or 
writing of this report. The trial was sponsored by Queen Mary University of London. All 
authors had full access to the final dataset and approved the final submitted version of this 
report.
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Results 
Fifteen geographic areas underwent randomisation including 97 NHS hospitals. Four hospitals 
withdrew before the start of the trial, leaving 93 participating. Between 3rd March 2014 and 
19th October 2015, 15,873 eligible patients underwent emergency abdominal surgery in 
participating hospitals with data recorded in the NELA database (8490 in the usual care group 
and 7383 in the QI group) (Figure 1). Baseline characteristics were similar between groups 
(Table 1).  
 
Process measures 
91/93 (98%) hospitals were represented at the initial QI meeting for the relevant geographical 
cluster and 53/93 (57%) were represented at the follow-up QI meeting. This representation 
included a named hospital QI lead for 89/93 (96%) hospitals at the first meeting and 47/93 
(51%) hospitals at the second. Most meetings (n=13/15) occurred within two weeks of the 
activation date. Patient-level process measures are described in Table 2. In accordance with 
our analysis plan, we did not test these for statistical significance. 
 
Clinical outcomes 
Complete primary outcome data were available for more than 99% of patients (Figure 1, 
Supplementary tables 1 and 2). The primary outcome of 90-day mortality occurred in 1393 
patients in the usual care group (16%) compared with 1210 patients in the QI group (16%) 
(Hazard ratio, QI vs usual care: 1.11 [0.96 to 1.28]) (Figure 2 and Table 3). Results were similar 
for mortality within 180 days (HR 1.12 [0.98 to 1.28]) (Supplementary figure 2). Patients in 
the QI group had a lower probability of hospital discharge (Hazard ratio for hospital discharge 
0.90 [0.83 to 0.97]), leading to a marginally longer hospital stay (days in hospital, usual care: 
8 [13 to 23] days vs. QI: 8 [13 to 24] days), although this difference was not clinically 
meaningful (Figure 3). There was no difference between groups in hospital re-admission 
within 180 days (usual care 1618 (20%) vs. QI 1242 (18%); Hazard ratio for re-admission 0.87 
[0.73 to 1.04]) (Supplementary figure 3). In a secondary analysis, we found no evidence that 
the QI strategy became more effective the longer it had been adopted (Supplementary table 
3). To assess the impact of missing mortality data following hospital discharge from patients 
in Wales, we assessed the number of mortality events which occurred after hospital discharge 
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but before 90 days in English and Scottish hospitals. Only 5% (631/13,034) of patients died 
between hospital discharge and 90 days, suggesting few outcome events in Wales were 
missed.  
 
Quality improvement and ethnographic findings 
Our prospective ethnographic study and process evaluation are reported in full 
elsewhere.26,27 The findings showed that teams reflected positively on the QI programme, in 
particular the practical nature of the activation and education meetings, and the opportunity 
to share ideas and learn from others as well as the utility of the online resources.  However, 
staff in each of the six sites studied encountered multiple challenges as they attempted to 
improve patient care during the intervention period and often had little or no additional time 
in their job plans to accommodate this. In particular, the task of collecting and entering data 
into the NELA database was more time consuming than expected. In addition, we observed 
differences in the fidelity with which teams used our recommended QI methods, differences 
in the clinical processes teams chose to attempt to change, the rate of this change and the 
eventual degree of success. Even amongst those sites that adhered to the QI intervention 
more closely, local adaptations to the care pathway were required to make this fit with the 
prevailing conditions of the hospital. The ethnographic evaluation confirmed the primarily 
social nature of the trial intervention. To a large extent, more successful QI teams drew on 
existing relationships within their hospital to influence colleagues and make change happen. 
Successful change seemed to be linked to the strength and number of these relationships; 
where these were lacking, additional effort was required to garner support for change. These 
findings suggest that whilst the QI programme may have provided QI leads and their teams 
with additional capabilities to lead change, the capacity to make change happen, especially in 
terms of protected time, was lacking. The extent to which the QI programme was delivered 
as intended, as well as enablers and barriers to change, are described in full in the report of 
the EPOCH trial process evaluation.27 
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Discussion 
The principal finding of this trial was that there was no survival benefit associated with a 
national quality improvement programme to implement an evidence-based care pathway for 
patients undergoing emergency abdominal surgery. Furthermore, there was no beneficial 
effect on 180-day mortality, hospital stay or hospital readmission. At a national level, there 
were only modest improvements amongst the ten measures selected to reflect key processes 
of care within the pathway. In some cases, the baseline rate of adherence to process 
measures was higher than anticipated. Experience from individual hospitals suggested wide 
variations in which of the 37 pathway elements local QI teams chose to tackle, the rate of 
change they achieved, and their eventual success. The baseline contexts of participating 
hospitals also differed. Implementation of change was slower where existing relationships 
within and beyond the perioperative team were weaker, and so QI leads had to spend time 
developing relationships with stakeholders. At the time of trial design, the EPOCH care 
pathway was widely agreed to represent an achievable standard of care that informed 
clinicians would wish to deliver for their patients, but commonly failed to provide because of 
poor awareness amongst the perioperative team. Our findings reveal that implementation of 
such an extensive care pathway was a more complex challenge than expected by our clinical 
community. It is important to interpret the results of this trial alongside those of the 
ethnographic study and process evaluation,26,27 which together suggest that quality 
improvement programmes designed to implement complex care pathways require more 
resources, with dedicated time for clinical teams to focus on making change happen.  
 
There are several published reports of the impact of small scale quality improvement projects 
to improve outcomes for patients undergoing emergency abdominal surgery. In the UK, the 
ELPQuiC group examined the implementation of a care bundle of five interventions in four 
NHS hospitals in an uncontrolled before and after study.4 They reported a reduction in 
mortality (risk ratio 0.61) amongst 726 patients. This study design is more prone to bias than 
a stepped-wedge cluster randomised trial.28 The difference in findings may additionally relate 
to the simpler intervention, and stronger pre-existing relationships between staff leading 
implementation in these early adopter hospitals. The simpler objective was more readily 
achieved than that of the national EPOCH trial which set more ambitious targets in hospitals 
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where there may have been a less favourable context for change. Researchers from Denmark 
reported differing results from three separate studies of perioperative quality improvement 
interventions for patients undergoing emergency abdominal surgery. The PULP trial group 
used an uncontrolled before and after design with historical controls to study the effect of a 
‘multidisciplinary perioperative care protocol’ in seven hospitals and reported a considerable 
reduction in 30-day mortality in comparison.6 However, 56 of the 173 patients allocated to 
the trial intervention were excluded from the analysis because they did not receive the full 
intervention, making it harder to interpret these findings. The InCare group did not identify 
any beneficial effect on 30-day survival from admission to an intermediate unit (critical care) 
amongst 286 patients undergoing emergency abdominal surgery in seven hospitals.5 This 
intervention appeared to change the process of patient care in the 48 hours following surgery, 
but the trial was stopped for futility partly because of a lower than expected mortality rate in 
both treatment arms. Finally, the AHA group again studied the effect of a multidisciplinary 
protocol in a single-centre uncontrolled before and after study with historical controls, finding 
a more modest reduction in 30-day mortality from 22% amongst 600 control patients to 16% 
amongst 600 intervention patients.7 It is possible that a background trend to improved 
mortality may explain the findings of these previous studies, especially given the growing 
international focus on poor patient outcomes following emergency abdominal surgery. Whilst 
our analysis accounts for temporal trends during the EPOCH trial, it is possible that a 
decreasing mortality beforehand may explain why the mortality rate was lower than that 
predicted from NHS registry data. Meanwhile, recent studies of quality improvement in other 
clinical areas have delivered mixed results.29-32 These findings suggest that more focussed, 
discrete clinical interventions may be more successfully implemented than interventions that 
include larger numbers of care processes. The evidence is less clear in defining the optimal 
improvement methods. There are several theoretical models of implementation including the 
Consolidated Framework for Implementation Research and the COM-B model.33,34  These 
provide frameworks for designing and evaluating effective implementation, clinical process 
and behaviour change. However, none of these models gives emphasis to institutional 
support or protected leadership time. Our findings suggest these more practical 
considerations are essential for clinicians to successfully lead quality improvement projects. 
In the EPOCH trial, teams were encouraged to begin with easier interventions, before building 
toward full pathway implementation. However, our process evaluation reveals that many 
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teams did not have the time or capacity to progress beyond simpler interventions (e.g. 
documentation of patient risk) to implementation of more important but challenging 
interventions such as admission to critical care. It is also important to note that the National 
Emergency Laparotomy Audit was launched only three months before the EPOCH trial 
commenced. Our ethnographic findings suggest that the task of collecting and entering data 
into the NELA database was more time consuming than expected, leaving some QI leads with 
little time to focus on change. We allowed a five-week period for the transition between usual 
care and the launch of the quality improvement programme in each cluster. Longer transition 
and intervention periods with dedicated time for QI leads to plan, negotiate and implement 
change may have led to more successful implementation. However, we also note that there 
was no evidence of survival benefit amongst hospitals exposed to the quality improvement 
programme for longer than 10 weeks, which included hospitals exposed for up to 80 weeks. 
 
The strengths of this trial include wide generalisability (large number of consecutive patients 
enrolled by many hospitals), robust trial design and the devolved leadership to local clinical 
QI teams. The EPOCH care pathway was developed through a Delphi consensus process to 
update national professional guidelines.8 As with many evidence-based treatment guidelines, 
some recommendations were graded as strong although the available evidence was weak. 
The choice of component interventions such as intensive care admission and consultant led 
care was primarily based on expert opinion; it is unclear how this evidence base could be 
improved. Partnership with the National Emergency Laparotomy Audit allowed an efficient 
trial design with no additional data collection for participating staff. However, our final 
dataset required linkage to four national registries in the devolved nations of the UK, and 
despite completing the trial on time, some organisations involved imposed substantial delays 
in access to these datasets. On several occasions, organisations changed their position on 
information governance regulations, requiring revision of previous agreements between each 
of the parties involved. In hindsight, we would have encountered fewer problems had we 
confined the trial to the jurisdictions of fewer organisations with information governance 
oversight. Despite the large sample, fewer patients than expected underwent emergency 
abdominal surgery, and the 90-day mortality rate was lower than anticipated. The sample size 
calculation was based on Hospital Episodes Statistics data which do not provide a specific 
diagnostic code for emergency abdominal surgery. Instead we identified a series of codes for 
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relevant procedures. We chose to power the trial to detect a very modest treatment effect 
partly to accommodate the possibility that these data were poorly representative of the 
EPOCH trial population. However, the 95% confidence interval for our primary effect estimate 
was narrow, with a lower limit which indicates a maximum potential mortality reduction of 
4%. Our findings are unlikely to change with a larger sample size. Due to difficulty in obtaining 
post-discharge survival data in Wales, we changed our primary analysis from a binary to a 
time to event approach allowing inclusion of mortality events censored at hospital discharge. 
However, post-discharge data from England and Scotland suggest few events were missed 
through this approach. The additional application required to obtain post-discharge mortality 
data for Wales would have further delayed the trial results by many months.  
 
Conclusions 
In this stepped-wedge cluster randomised trial, we did not identify any survival benefit from 
a national quality improvement programme to implement an enhanced pathway of care for 
patients undergoing emergency abdominal surgery. This is likely due to variation between 
hospitals in fidelity of implementation, prioritisation of pathway components, and the time 
required to achieve effective change. These findings suggest future quality improvement 
programmes should implement fewer, more discrete changes and ensure leadership teams 
have adequate time to achieve sustained improvements in patient care. Undue emphasis on 
success stories from small early studies may lead us to under-estimate the requirements for 
successful quality improvement interventions. 
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Table 1. Baseline patient characteristics. Data presented as n (%) unless otherwise indicated. 
ASA: American Society of Anesthesiologists physical status score; P-POSSUM: Portsmouth Physiological and 
Operative Severity Score for the enumeration of Mortality and morbidity score. 
 
 
Number of patients with missing 
data (n %) 
Summary measure 
 
Usual care 
(n=8490) 
Quality 
improvement 
(n=7383) 
Usual care 
Quality 
improvement 
Baseline characteristics     
Female 0 (0) 0 (0) 4550 (54) 3938 (53) 
Age – mean (SD) 0 (0) 0 (0) 68 (13) 68 (13) 
Indication for surgery 13 (<1) 5 (<1)   
     Peritonitis - - 352 (4) 251 (3) 
     Perforation - - 765 (9) 693 (9) 
     Intestinal obstruction - - 3840 (45) 3379 (46) 
     Haemorrhage - - 213 (3) 149 (2) 
     Ischaemia - - 366 (4) 332 (5) 
     Abdominal infection - - 296 (3) 239 (3) 
     Other - - 523 (6) 472 (6) 
     Multiple indications - - 2122 (25) 1863 (25) 
Pre-operative characteristics     
Estimated risk of death 158 (2) 22 (<1)   
     Not documented - - 3762 (45) 2468 (34) 
     Low (<5%) - - 1354 (16) 1646 (22) 
     Medium (5-10%) - - 1019 (12) 1102 (15) 
     High (>10%) - - 2197 (26) 2145 (29) 
ASA grade 156 (2) 23 (<1)   
     I (No systemic disease) - - 615 (7) 533 (7) 
     II (Mild systemic disease) - - 2815 (34) 2461 (33) 
     III (Severe systemic disease) - - 3112 (37) 2745 (37) 
     IV (life threatening systemic disease) - - 1605 (19) 1465 (20) 
     V (Moribund patient) - - 187 (2) 156 (2) 
P-POSSUM score (median [IQR]) 152 (2) 13 (<1) 7.6 (2.9-22.7) 7.4 (2.8-22.9) 
Systolic blood pressure (mean [SD]) 255 (3) 147 (2) 128 (24) 128 (25) 
Glasgow coma score (mean [SD]) 221 (3) 72 (1) 14.8 (1.4) 14.7 (1.5) 
Blood lactate (median [IQR)] 4103 (48) 2870 (39) 1.6 (1.1-2.8) 1.5 (1.0-2.6) 
20 
 
Table 2. Patient level process measures. Data presented as n (%). a 29 patients in the usual 
care group and 27 patients in the QI group died during surgery. 
 
 
 
Number of patients with 
missing data (n %) 
Summary measure 
Process measure 
Usual care 
(n=8490) 
Quality 
improvement 
(n=7383) 
Usual care 
Quality 
improvement 
Consultant decision to operate 184 (2) 72 (1) 7472 (90) 6589 (90) 
Consultant reviewed patient at 
time of decision 
448 (6) 334 (5) 5961 (85) 5271 (84) 
Pre-operative documentation of 
risk 
158 (2) 22 (<1) 4570 (55) 4893 (66) 
Patient entered operating 
theatre within specified urgency 
time frame 
1012 (12) 430 (6) 5636 (75) 5515 (79) 
Consultant surgeon present in 
operating theatre 
155 (2) 17 (<1) 7117 (85) 6472 (88) 
Consultant anaesthetist present 
in operating theatre 
160 (2) 14 (<1) 6313 (76) 5832 (79) 
Goal directed fluid therapy used 
during surgery 
180 (2) 24 (<1) 3942 (47) 4329 (59) 
Serum lactate measured at end 
of surgery 
171 (2) 24 (<1) 4474 (54) 4431 (60) 
Time from decision to operate to 
entry into operating theatre 
(hours) 
630 (7) 417 (6) 5.0 (2.1-16.8) 4.3 (2.0-15.3) 
Critical care admission 
immediately after surgerya 
163 (2) 22 (<1) 5395 (65) 5050 (69) 
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Table 3. Patient outcomes. Data presented as median (IQR), n (%) or hazard ratio with 95% 
confidence intervals. 
 
 Number of patients included 
in analysis 
Summary outcome measure 
 
Usual care 
(n=8490) 
Quality 
improvement 
(n=7383) 
Usual care 
Quality 
improvement 
Hazard ratio 
(QI vs. usual care) 
All-cause mortality within 
90 days of surgery  
8482 (>99) 7374 (>99) 1393 (16) 1210 (16) 
1.11 
(0.96-1.28) 
All-cause mortality within 
180 days of surgery 
8482 (>99) 7374 (>99) 1698 (20) 1440 (20) 
1.12 
(0.98-1.28) 
Duration of hospital stay 
(days) 
8320 (98) 7353 (>99) 
8 
(13-23) 
8 
(13-24) 
0.90 
(0.83-0.97) 
Hospital re-admission 
within 180 days of surgery 
7969 (94) 6723 (91) 1618 (20) 1242 (18) 
0.87 
(0.73-1.04) 
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Figure 1. Inclusion of hospitals and patients in the trial. NELA: National Emergency 
Laparotomy Audit. 
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Figure 2. Mortality within 90 days of emergency abdominal surgery. QI: quality 
improvement group. 
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Figure 3. Duration of hospital stay after emergency abdominal surgery. QI: quality 
improvement group. 
 
 
 
